Complete financial analysis of Huadong Medicine Co., Ltd (000963.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Huadong Medicine Co., Ltd, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Future Consumer Limited (FCONSUMER.NS) Income Statement Analysis – Financial Results
- Realty Income Corporation (RY6.DU) Income Statement Analysis – Financial Results
- Inox Green Energy Services Limited (INOXGREEN.BO) Income Statement Analysis – Financial Results
- PT Arkadia Digital Media Tbk (DIGI.JK) Income Statement Analysis – Financial Results
- Global Dominion Access, S.A. (DOM.MC) Income Statement Analysis – Financial Results
Huadong Medicine Co., Ltd (000963.SZ)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.eastchinapharm.com
About Huadong Medicine Co., Ltd
Huadong Medicine Co., Ltd produces and sells various pharmaceutical products in China. It offers Chinese patent drugs, immunosuppressive agents, endocrine drugs, digestive system drugs, antineoplastic drugs, cardiovascular drugs, medical cosmetology, and antibiotic drugs, as well as medical equipment. The company's products include gastrointestinal agents, APIs, and other products. It also engages in the production and management of traditional Chinese and western raw medicines and preparations, and health care products; wholesale of TCM materials, TCM decoction pieces, chemical preparations, etc.; warehousing and storage business; and research, development, production, and sale of aesthetic medicine products. Huadong Medicine Co., Ltd was founded in 1993 and is headquartered in Hangzhou, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 40.39B | 37.71B | 34.56B | 33.68B | 35.45B | 30.66B | 27.83B | 25.38B | 21.73B | 18.95B | 16.72B | 14.58B | 11.13B | 8.97B | 7.82B | 6.02B | 4.85B | 3.94B | 3.48B | 2.88B | 2.33B | 2.07B | 1.89B | 1.62B | 1.25B | 1.14B | 981.13M | 669.74M |
| Cost of Revenue | 27.85B | 25.68B | 23.96B | 22.55B | 24.09B | 21.77B | 20.56B | 19.22B | 16.52B | 14.78B | 13.34B | 11.73B | 8.95B | 7.29B | 6.26B | 4.85B | 3.81B | 3.17B | 2.86B | 2.39B | 1.95B | 1.75B | 1.58B | 1.34B | 1.03B | 948.75M | 830.39M | 604.31M |
| Gross Profit | 12.54B | 12.03B | 10.61B | 11.13B | 11.36B | 8.89B | 7.27B | 6.16B | 5.21B | 4.16B | 3.38B | 2.85B | 2.18B | 1.68B | 1.56B | 1.17B | 1.04B | 767.47M | 625.83M | 489.99M | 380.36M | 313.65M | 306.25M | 273.94M | 213.46M | 190.35M | 150.74M | 65.43M |
| Gross Profit Ratio | 31.04% | 31.90% | 30.69% | 33.05% | 32.05% | 28.99% | 26.12% | 24.27% | 23.98% | 21.98% | 20.20% | 19.54% | 19.63% | 18.76% | 19.98% | 19.36% | 21.41% | 19.47% | 17.96% | 17.00% | 16.35% | 15.18% | 16.23% | 16.93% | 17.13% | 16.71% | 15.36% | 9.77% |
| Research & Development | 1.27B | 1.02B | 979.64M | 926.73M | 1.07B | 706.04M | 461.75M | 264.09M | 217.74M | 172.54M | 160.85M | 125.23M | 101.90M | 89.08M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 466.41M | 524.06M | 515.37M | 465.59M | 536.10M | 369.58M | 267.75M | 222.80M | 227.11M | 224.78M | 169.50M | 136.07M | 96.46M | 68.69M | 247.00M | 242.16M | 212.79M | 200.32M | 171.78M | 172.44M | 146.61M | 101.52M | 88.60M | 91.59M | 63.80M | 46.28M | 37.32M | 22.94M |
| Selling & Marketing | 4.62B | 6.33B | 5.42B | 5.98B | 5.82B | 4.32B | 3.73B | 3.30B | 2.77B | 2.13B | 1.74B | 1.44B | 1.12B | 871.91M | 666.70M | 532.87M | 448.82M | 368.46M | 298.56M | 222.37M | 165.93M | 135.82M | 115.31M | 101.90M | 76.23M | 75.96M | 55.15M | 14.12M |
| SG&A | 7.81B | 6.86B | 5.94B | 6.45B | 6.36B | 4.69B | 4.00B | 3.52B | 3.00B | 2.35B | 1.91B | 1.57B | 1.22B | 940.60M | 913.70M | 775.03M | 661.61M | 568.78M | 470.35M | 394.82M | 312.54M | 237.34M | 203.92M | 193.49M | 140.03M | 122.24M | 92.47M | 37.06M |
| Other Expenses | 0.00 | 840.27M | 654.13M | 513.85M | 603.39M | 481.52M | -16.90M | 41.76M | 39.66M | 17.82M | 20.41M | 7.24M | 5.25M | 37.02M | 31.79M | 10.21M | 1.71M | 19.15M | 21.20M | 25.10M | 24.26M | 21.31M | -1.68M | 1.19M | 9.64M | 7.62M | 862.28K | 447.19K |
| Operating Expenses | 9.71B | 8.72B | 7.57B | 7.89B | 8.03B | 5.88B | 4.87B | 4.19B | 3.60B | 2.83B | 2.31B | 1.92B | 1.47B | 1.15B | 952.75M | 789.16M | 681.66M | 574.58M | 473.67M | 397.17M | 313.86M | 240.86M | 207.67M | 197.26M | 141.75M | 123.92M | 94.42M | 38.35M |
| Cost & Expenses | 36.80B | 34.40B | 31.53B | 30.44B | 32.12B | 27.65B | 25.43B | 23.41B | 20.11B | 17.62B | 15.65B | 13.65B | 10.41B | 8.43B | 7.21B | 5.64B | 4.50B | 3.75B | 3.33B | 2.79B | 2.26B | 1.99B | 1.79B | 1.54B | 1.17B | 1.07B | 924.81M | 642.66M |
| Interest Income | 94.05M | 103.35M | 80.40M | 60.99M | 30.59M | 35.31M | 31.88M | 28.90M | 9.64M | 8.51M | 7.72M | 6.55M | 8.70M | 5.45M | 0.00 | -0.26 | -0.17 | 7.48M | 7.74M | 5.94M | 6.10M | 2.99M | 9.80M | 7.18M | -0.55 | -0.44 | -0.31 | -0.82 |
| Interest Expense | 144.20M | 125.10M | 72.50M | 68.64M | 107.19M | 114.94M | 74.47M | 97.14M | 194.09M | 150.08M | 128.11M | 137.03M | 117.54M | 65.20M | 51.08M | 68.00M | 55.34M | 45.64M | 41.25M | 31.82M | 21.79M | 17.98M | 18.06M | 16.76M | 15.13M | 19.19M | 15.26M | 14.44M |
| Depreciation & Amortization | 818.35M | 711.31M | 596.36M | 439.55M | 411.23M | 327.14M | 277.40M | 215.53M | 158.85M | 134.53M | 119.02M | 98.74M | 84.67M | 71.97M | 60.64M | 45.59M | 44.92M | 44.64M | 41.37M | 34.19M | 31.51M | 24.38M | 13.59M | 12.70M | 10.67M | 6.50M | 11.95M | 12.88M |
| EBITDA | 4.39B | 4.00B | 3.58B | 3.99B | 3.99B | 3.20B | 2.67B | 2.11B | 1.60B | 1.33B | 1.08B | 902.13M | 710.58M | 579.45M | 672.28M | 421.49M | 402.94M | 261.99M | 223.87M | 163.53M | 127.04M | 121.96M | 126.22M | 96.98M | 82.38M | 68.05M | 56.32M | 27.08M |
| EBITDA Ratio | 10.87% | 10.33% | 10.27% | 10.86% | 10.98% | 10.94% | 9.69% | 8.87% | 8.33% | 7.85% | 7.29% | 7.14% | 7.46% | 7.34% | 8.97% | 7.63% | 8.30% | 6.59% | 6.37% | 5.58% | 5.46% | 5.90% | 6.69% | 6.03% | 6.64% | 6.40% | 5.74% | 4.04% |
| Operating Income | 3.59B | 3.06B | 2.86B | 3.48B | 3.40B | 2.91B | 2.34B | 1.86B | 1.38B | 1.16B | 924.84M | 782.67M | 610.44M | 461.70M | 536.78M | 273.00M | 303.20M | 170.93M | 139.75M | 90.77M | 72.43M | 80.35M | 97.05M | 69.97M | 55.58M | 53.64M | 44.38M | 14.20M |
| Operating Income Ratio | 8.88% | 8.12% | 8.26% | 10.32% | 9.58% | 9.49% | 8.41% | 7.31% | 6.36% | 6.11% | 5.53% | 5.37% | 5.48% | 5.15% | 6.86% | 4.54% | 6.25% | 4.34% | 4.01% | 3.15% | 3.11% | 3.89% | 5.14% | 4.33% | 4.46% | 4.71% | 4.52% | 2.12% |
| Total Other Income/Expenses | -121.85M | -30.33M | -28.18M | -23.18M | 73.22M | -55.73M | -31.69M | -42.36M | -159.97M | -137.94M | -103.96M | -130.13M | -95.67M | -25.16M | -22.05M | -93.60M | -53.53M | -659.15K | -34.65M | 4.03M | 1.30M | -749.82K | -2.48M | -2.45M | 7.11M | -8.09M | -1.29M | -722.70K |
| Income Before Tax | 3.47B | 3.03B | 2.83B | 3.45B | 3.47B | 2.87B | 2.32B | 1.88B | 1.42B | 1.17B | 942.29M | 787.52M | 612.86M | 495.49M | 565.16M | 282.31M | 303.97M | 169.37M | 139.23M | 94.80M | 73.73M | 79.60M | 94.57M | 68.46M | 62.69M | 59.23M | 43.09M | 13.48M |
| Income Before Tax Ratio | 8.58% | 8.04% | 8.18% | 10.25% | 9.79% | 9.37% | 8.35% | 7.42% | 6.54% | 6.19% | 5.64% | 5.40% | 5.51% | 5.52% | 7.22% | 4.69% | 6.26% | 4.30% | 4.00% | 3.29% | 3.17% | 3.85% | 5.01% | 4.23% | 5.03% | 5.20% | 4.39% | 2.01% |
| Income Tax Expense | 619.59M | 498.50M | 488.91M | 543.67M | 544.86M | 477.37M | 436.16M | 346.86M | 267.79M | 230.11M | 194.63M | 166.96M | 126.81M | 99.62M | 117.91M | 54.99M | 77.76M | 48.17M | 53.63M | 49.49M | 33.33M | 23.79M | 27.77M | 12.88M | 13.03M | 12.20M | 8.61M | 4.57M |
| Net Income | 2.84B | 2.50B | 2.30B | 2.82B | 2.81B | 2.27B | 1.78B | 1.45B | 1.10B | 756.67M | 574.98M | 469.93M | 381.48M | 317.31M | 378.42M | 168.61M | 173.16M | 83.35M | 67.31M | 30.58M | 30.58M | 46.53M | 57.48M | 45.91M | 40.35M | 40.25M | 30.38M | 8.91M |
| Net Income Ratio | 7.03% | 6.63% | 6.66% | 8.37% | 7.94% | 7.39% | 6.39% | 5.70% | 5.05% | 3.99% | 3.44% | 3.22% | 3.43% | 3.54% | 4.84% | 2.80% | 3.57% | 2.11% | 1.93% | 1.06% | 1.31% | 2.25% | 3.05% | 2.84% | 3.24% | 3.53% | 3.10% | 1.33% |
| EPS | 1.62 | 1.43 | 1.32 | 1.61 | 1.61 | 1.29 | 1.02 | 0.83 | 0.70 | 0.48 | 0.37 | 0.30 | 0.24 | 0.20 | 0.24 | 0.11 | 0.11 | 0.07 | 0.03 | 0.02 | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | 0.03 | 0.02 | 0.01 |
| EPS Diluted | 1.62 | 1.43 | 1.32 | 1.61 | 1.61 | 1.29 | 1.02 | 0.83 | 0.70 | 0.48 | 0.37 | 0.30 | 0.24 | 0.20 | 0.24 | 0.11 | 0.11 | 0.07 | 0.03 | 0.02 | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | 0.03 | 0.02 | 0.01 |
| Weighted Avg Shares Out | 1.75B | 1.75B | 1.75B | 1.75B | 1.75B | 1.76B | 1.75B | 1.74B | 1.56B | 1.57B | 1.57B | 1.57B | 1.56B | 1.56B | 1.57B | 1.56B | 1.56B | 1.39B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B |
| Weighted Avg Shares Out (Dil) | 1.75B | 1.75B | 1.75B | 1.75B | 1.75B | 1.76B | 1.75B | 1.74B | 1.56B | 1.57B | 1.57B | 1.57B | 1.56B | 1.56B | 1.57B | 1.56B | 1.56B | 1.39B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B |
No news found for: 000963.SZ
Source: https://incomestatements.info
Category: Stock Reports